Clinical trialNCT02959489CompletedInterventional

Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)

SponsorBrigham and Women's HospitalEnrollment315Alzheimer DiseaseAmyloid Beta-PeptidesEducationNeuroimagingNeuropsychological TestsRisk Assessment

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

J. Scott Roberts, PhD
University of Michigan
Principal Investigator
clinicaltrials.gov ↗
Jason Karlawish, MD
University of Pennsylvania
Principal Investigator
clinicaltrials.gov ↗
Kathleen Welsh-Boomer, PhD
Duke University
Principal Investigator
clinicaltrials.gov ↗
Robert C Green, MD, MPH
Brigham and Women's Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Brigham and Women'S Hospital
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Duke University
Durham, North Carolina, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2016
Primary completion: 13 May 2020
Completion: 29 Apr 2021
Last update posted: 2 Apr 2024
Registered enrollment: 315
Registry id: NCT02959489

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.